Tag: market research

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

"Advances in proteomics technologies are driving growth in precision medicine, with rising demand for early diagnostics, personalized therapies, and deeper insights into disease mechanisms." BOSTON,...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of...

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.

17 Percent MEC CAGR Driven by Network APIs, Network Slicing, and RedCap REDWOOD CITY, Calif., July 24, 2025 /PRNewswire/ -- According to a recently published report...

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The report "Electro-Oxidation Market by Type (Direct Electro-Oxidation, Indirect Electro-Oxidation), Electrode Material (Boron-Doped Diamond (BBD), Lead...

DELRAY BEACH, Fla., July 24, 2025 /PRNewswire/ -- The report "Electro-Oxidation Market by Type (Direct Electro-Oxidation, Indirect Electro-Oxidation), Electrode Material (Boron-Doped Diamond (BBD), Lead...

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in our comprehensive report. Stay ahead with insights on market trends, technology, and growth potential.

Flow Cytometry's growth accelerates as immuno-oncology and liquid biopsy markets expand, driving cancer research investment. Explore advancements in single-cell genomics and biotech opportunities in our comprehensive report. Stay ahead with insights on market trends, technology, and growth potential.

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

Claudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Information Services Market size & share revenue was valued at approximately USD 168.37 Billion in 2024 and is expected to reach USD 179.73 Billion in 2025 and is expected to reach around USD 327.94 Billion by 2034, at a CAGR of 6.91% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Wolters Kluwer NV, United Press International Inc., Thomson Reuters Corp., The New York Times Co., S&P Global Inc., RELX Plc, Nexstar Media Group Inc., News Corp., Moody’s Corp., GISP Group, FUJIFILM Holdings Corp., Clarivate PLC, Bloomberg LP, Australian Associated Press Ltd., AGS Corp., Agence France Presse and others.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Information Services Market size & share revenue was valued at approximately USD 168.37 Billion in 2024 and is expected to reach USD 179.73 Billion in 2025 and is expected to reach around USD 327.94 Billion by 2034, at a CAGR of 6.91% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Wolters Kluwer NV, United Press International Inc., Thomson Reuters Corp., The New York Times Co., S&P Global Inc., RELX Plc, Nexstar Media Group Inc., News Corp., Moody’s Corp., GISP Group, FUJIFILM Holdings Corp., Clarivate PLC, Bloomberg LP, Australian Associated Press Ltd., AGS Corp., Agence France Presse and others.